Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Healthy Returns: AstraZeneca, Pfizer, Gilead release cancer drug data

Pfizer Seeks Mass Tort Coordination of Phila. Depo-Provera Lawsuits

Pfizer Inc. (NYSE:PFE) Position Increased by Sentry Investment Management LLC

Pfizer Inc. (NYSE:PFE) Stock Holdings Lifted by NBC Securities Inc.

How Moderna Went From Pandemic Hero to Vaccine Victim

Rep. Robert Bresnahan, Jr. Purchases Shares of Pfizer Inc. (NYSE:PFE)

Jim Cramer Says "We Can Own The Stock of Pfizer (PFE)" - Insider Monkey

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics | Morningstar

us companies layoffs: Morgan Stanley, Walmart, Pfizer and more: Full list of over 150 American companies laying off employees in June - The Economic Times

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race | Morningstar

Pfizer Inc. (NYSE:PFE) Shares Bought by Gradient Investments LLC

Sarasin & Partners LLP Lowers Stock Position in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Moderate Buy" from Analysts

Bernstein Keeps Their Hold Rating on Pfizer (PFE) | Markets Insider

Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance | Markets Insider

Advance Capital Management Inc. Sells 479 Shares of Pfizer Inc. (NYSE:PFE)

Addenda Capital Inc. Buys 57,025 Shares of Pfizer Inc. (NYSE:PFE)

New research presents promising findings on colorectal cancer treatment and prevention | CNN

Czech National Bank Has $32.98 Million Position in Pfizer Inc. (NYSE:PFE)

JGP Wealth Management LLC Sells 12,939 Shares of Pfizer Inc. (NYSE:PFE)

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia

Parallel Advisors LLC Increases Holdings in Pfizer Inc. (NYSE:PFE)

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics | Morningstar

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer | Morningstar

Pfizer Reveals Phase 3 Results For Vepdegestrant In Advanced Breast Cancer Treatment

Bath Savings Trust Co Sells 27,842 Shares of Pfizer Inc. (NYSE:PFE)

Siemens Fonds Invest GmbH Has $43,000 Position in Pfizer Inc. (NYSE:PFE)

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Novel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial

'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views

Benchmark Wealth Management LLC Decreases Holdings in Pfizer Inc. (NYSE:PFE)

Town & Country Bank & Trust CO dba First Bankers Trust CO Has $641,000 Position in Pfizer Inc. (NYSE:PFE)

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript

Unlocking India's Clinical Trial Potential: Experts Discuss India's Race to Challenge China's Pharma Dominance, ETPharma

Welch Group LLC Buys 794,076 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Acquired by Tompkins Financial Corp

Pfizer's BRAFTOVI Combo Cuts Risk Of Death By Half For BRAF V600E-mutant Colorectal Cancer Patients

Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate Cancer Care | The Manila Times

Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate Cancer Care | Morningstar

Centre Asset Management LLC Reduces Stake in Pfizer Inc. (NYSE:PFE)

Avant Financial Advisors LLC Invests $332,000 in Pfizer Inc. (NYSE:PFE)

111 Capital Invests $509,000 in Pfizer Inc. (NYSE:PFE)
Abrysvo or Arexvy Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029F, 2034F

China's biotech having its 'DeepSeek' moment amid big pharma M&A spree: ORI Capital founder

More Ontario doctors choosing specialty care, report says | Watch News Videos Online

Biopharma Industry in 2025: Growth Drivers, AI Innovation & Market Forecasts | Morningstar

Thoma Capital Management LLC Invests $523,000 in Pfizer Inc. (NYSE:PFE)

Lighthouse Financial LLC Takes Position in Pfizer Inc. (NYSE:PFE)

Belly Fat May Be an Independent Risk Factor for Psoriasis, Study Suggests

Rogan & Rodgers Unleash Big Pharma's Worst Nightmare... | ZeroHedge

CDC ends Covid vaccine recommendation for healthy kids and pregnant women

Arcadia Wealth Management Inc. Takes Position in Pfizer Inc. (NYSE:PFE)

266,802 Shares in Pfizer Inc. (NYSE:PFE) Acquired by QSM Asset Management Ltd

Pfizer Inc. (NYSE:PFE) Holdings Lowered by Mackenzie Financial Corp

BAJAJ HEALTHCARE Share Price Today Down 7%

Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

New Canadian guidelines issued for managing hypertension | Watch News Videos Online

Sculati Wealth Management LLC Sells 5,305 Shares of Pfizer Inc. (NYSE:PFE)

Ameriflex Group Inc. Makes New Investment in Pfizer Inc. (NYSE:PFE)

Leigh Baldwin & CO. LLC Takes Position in Pfizer Inc. (NYSE:PFE)

Lakeshore Capital Group Inc. Takes $324,000 Position in Pfizer Inc. (NYSE:PFE)

Health Matters: CMA wants parliament to prioritize health care promises | Watch News Videos Online

Sickle Cell Disease Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Prevalence, Medication, Statistics, NICE Approval.Revenue and Companies by DelveInsight | ABNewswire

Lavenhill Securities Limited analyzes Pfizer's $6B deal as strategic pharma expansion -- Lavenhill Securities Limited | PRLog

Challenger Wealth Management Purchases New Position in Pfizer Inc. (NYSE:PFE)

25,379 Shares in Pfizer Inc. (NYSE:PFE) Bought by PVG Asset Management Corp

Pfizer Inc. (NYSE:PFE) Position Cut by B. Riley Wealth Advisors Inc.

Leigh Baldwin & CO. LLC Makes New $1.73 Million Investment in Pfizer Inc. (NYSE:PFE)

Griffith & Werner Inc. Invests $2.73 Million in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Stake Lowered by Western Wealth Management LLC

GF Fund Management CO. LTD. Takes Position in Pfizer Inc. (NYSE:PFE)

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion

Assessment of a non-invasive approach for pressure volume loop prediction in mice

Auxier Asset Management Cuts Position in Pfizer Inc. (NYSE:PFE)

Formidable Asset Management LLC Sells 507 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost

Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio

Pfizer Inc. (NYSE:PFE) Shares Purchased by Sunbelt Securities Inc.

Novem Group Takes Position in Pfizer Inc. (NYSE:PFE)

Concurrent Gainers: 6 stocks gain for 5 days in a row

PFE Stock: Is Pfizer's 7.5% Dividend Too Good to Last?

Pfizer (NYSE:PFE) Stock Price Down 1% - Should You Sell?

Navalign LLC Sells 990 Shares of Pfizer Inc. (NYSE:PFE)

JT Stratford LLC Acquires 7,240 Shares of Pfizer Inc. (NYSE:PFE)

First Heartland Consultants Inc. Sells 1,972 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Purchased by Breed s Hill Capital LLC

Css LLC Il Trims Stock Position in Pfizer Inc. (NYSE:PFE)

Waverly Advisors LLC Sells 57,845 Shares of Pfizer Inc. (NYSE:PFE)

FDA may change Covid-19 booster rules from 2025: What it means for you

Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | The Manila Times

Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting - PR Newswire APAC

Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | Morningstar

Cell and Gene Therapies in Rare Disorders Market on Track for Major Expansion by 2034, According to DelveInsight | Pfizer, Sangamo Therapeutics, Orchard Therapeutics, SR-Tiget, Novartis, TVAX Biomed | ABNewswire

Dr. Peter McCullough: Covid Vaccine Myocarditis Is Real, Over 200 Deaths This Year
PFIZER News

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
AI Stock Analysis: PLTR Hits Record High as Government Deals Fuel Momentum

ACHR Stock Analysis: What’s Driving Archer Aviation's Market Performance?

Morning Note: ADP Jobs Report Eyed; BoC Rate Decision; ISM Services PMI

Morning Note: CrowdStrike Reports; Gold Rises on Tensions; Dollar Falls Amid Trade Fears